Breast cancer cells treated with calcitriol decrease the expression of ZEB1, N-cadherin, vimentin, or integrins and increase the level of E-cadherin, suggesting that calcitriol reduces the EMT process [78]. The gene discussed is CDH1; the disease is breast cancer.